|
?:authorAffiliation
|
-
[\'Department of Pharmaceutical Outcomes and Policy, University of Florida College of Pharmacy, Gainesville, FL, USA. tang.huilin@ufl.edu.\', \'Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina At Chapel Hill, Chapel Hill, NC, USA.\', \'Institute for Drug Evaluation, Peking University Health Science Center, Beijing, China.\', \'Division of Pharmaceutical Outcome and Policy, University of North Carolina School of Pharmacy, Chapel Hill, NC, USA.\', \'Cecil G. Sheps Center for Health Services Research, University of North Carolina At Chapel Hill, Chapel Hill, NC, USA.\', \'Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina At Chapel Hill, Chapel Hill, NC, USA.\', \'Center for Gastrointestinal Biology and Disease, School of Medicine, University of North Carolina At Chapel Hill, Chapel Hill, NC, USA.\', \'Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina At Chapel Hill, Chapel Hill, NC, USA.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}